ID   AMC-HN-9
AC   CVCL_5967
SY   Amc-HN-9; AMC-HN9; Asian Medical Center-Head and Neck cancer-9
DR   Wikidata; Q54749724
RX   PubMed=9349880;
RX   PubMed=11039880;
RX   PubMed=24336076;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=24336076).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
RX   PubMed=9349880; DOI=10.3109/00016489709113477;
RA   Kim S.Y., Chu K.-C., Lee H.R., Lee K.-S., Carey T.E.;
RT   "Establishment and characterization of nine new head and neck cancer
RT   cell lines.";
RL   Acta Oto-Laryngol. 117:775-784(1997).
//
RX   PubMed=11039880; DOI=10.1080/000164800750000513;
RA   Kim S.H., Carey T.E., Liebert M., Yoo S.J., Kwon H.J., Kim S.Y.;
RT   "Characterization of AMC-HN-9, a cell line established from an
RT   undifferentiated carcinoma of the parotid gland: expression of
RT   alpha6beta4 with the absence of BP180 and 230.";
RL   Acta Oto-Laryngol. 120:660-666(2000).
//
RX   PubMed=24336076; DOI=10.1038/cddis.2013.488; PMCID=PMC3877559;
RA   Roh J.-L., Kim E.H., Park H.B., Park J.Y.;
RT   "The Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin
RT   increases cisplatin antitumor activity by inducing p53-mediated
RT   apoptosis in head and neck cancer.";
RL   Cell Death Dis. 4:e956.1-e956.8(2013).
//